podophyllotoxin has been researched along with acridines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansen, HF; Jensen, LH; Jensen, PB; Nitiss, JL; Rothenborg-Jensen, L; Schmidt, G; Sehested, M; Wessel, I | 1 |
| Andricopulo, AD; da Fonseca, MB; Graebin, CS; Magalhaes, LG; Marques, FB; Rogério, KR | 1 |
| BALIS, ME; PECORA, PF | 1 |
3 other study(ies) available for podophyllotoxin and acridines
| Article | Year |
|---|---|
Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Topics: Aclarubicin; Acridines; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport, Active; Cell Survival; Cross-Linking Reagents; DNA; DNA Damage; DNA Topoisomerases, Type II; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; In Vitro Techniques; Mutation; Podophyllotoxin; Polymerase Chain Reaction; Razoxane; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2001 |
Discovery of a Series of Acridinones as Mechanism-Based Tubulin Assembly Inhibitors with Anticancer Activity.
Topics: Acridines; Antineoplastic Agents; Apoptosis; Binding Sites; Binding, Competitive; Cell Cycle; Cell Line, Tumor; Cell Movement; Colchicine; Drug Design; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Podophyllotoxin; Tubulin; Tubulin Modulators | 2016 |
EFFECTS OF ANTIMITOTIC AGENTS ON EHRLICH ASCITES CELLS.
Topics: Acridines; Adenine; Amino Acids; Animals; Antimetabolites; Antimitotic Agents; Antineoplastic Agents; Ascites; Carbon Isotopes; Carcinoma, Ehrlich Tumor; DNA; DNA, Neoplasm; Glycine; Guanine; Hypoxanthines; Pharmacology; Podophyllum; Purines; Research; RNA; RNA, Neoplasm; Thymidine; Tritium; Xanthines | 1964 |